Head-to-head comparison of 68 Ga-FAPI-46 PET/CT, 18F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
Masao Watanabe(Juntendo University Urayasu Hospital), Manuel Weber(Essen University Hospital), Stefan Kasper(Essen University Hospital), Hong Grafe(Essen University Hospital), Bastian von Tresckow(University of Cologne), David Kersting(West German Heart and Vascular Center Essen), Kim M. Pabst(West German Heart and Vascular Center Essen), Wolfgang P. Fendler(Essen University Hospital), Helena Lanzafame(Essen University Hospital), Fadi Zarrad(Essen University Hospital), Martin Stuschke(Essen University Hospital), Jens T. Siveke(German Cancer Research Center), Céline Lugnier(Ruhr University Bochum), Hubertus Hautzel(Deutsches Konsortium für Translationale Krebsforschung), Nader Hirmas(German Breast group), Boris Hadaschik(Essen University Hospital), Rainer Hamacher(Essen University Hospital), Clemens Aigner(Comprehensive Cancer Center Vienna), Viktor Grünwald(Deutsche Schmerzgesellschaft), Sherko Kümmel(Kliniken Essen-Mitte), Ken Herrmann(Essen University Hospital)
Cited by 15
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k